TECH logo

Bio-Techne (TECH) Cash From Operations

Annual CFO

$298.98 M
+$44.59 M+17.53%

30 June 2024

TECH Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

$63.89 M
-$11.61 M-15.37%

30 September 2024

TECH Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

$303.49 M
+$4.51 M+1.51%

30 September 2024

TECH TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TECH Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.5%-23.1%+9.8%
3 y3 years-15.1%-36.7%-12.4%
5 y5 years+64.6%-9.3%+46.9%

TECH Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-15.1%+17.5%-37.8%+31.9%-12.4%+19.3%
5 y5 years-15.1%+64.6%-47.6%+57.6%-13.8%+66.1%
alltimeall time-15.1%>+9999.0%-47.6%+1946.1%-13.8%>+9999.0%

Bio-Techne Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2024
-
$63.89 M(-15.4%)
$303.49 M(+1.5%)
June 2024
$298.98 M(+17.5%)
$75.50 M(-6.8%)
$298.98 M(-2.6%)
Mar 2024
-
$80.99 M(-2.6%)
$306.88 M(+11.0%)
Dec 2023
-
$83.12 M(+40.0%)
$276.43 M(+7.3%)
Sept 2023
-
$59.38 M(-28.8%)
$257.69 M(+1.3%)
June 2023
$254.39 M(-21.8%)
$83.39 M(+65.0%)
$254.39 M(-7.1%)
Mar 2023
-
$50.53 M(-21.5%)
$273.72 M(-7.6%)
Dec 2022
-
$64.38 M(+14.8%)
$296.31 M(-11.0%)
Sept 2022
-
$56.08 M(-45.4%)
$332.92 M(+2.4%)
June 2022
$325.27 M(-7.6%)
$102.72 M(+40.5%)
$325.27 M(-5.6%)
Mar 2022
-
$73.13 M(-27.6%)
$344.57 M(-0.5%)
Dec 2021
-
$100.99 M(+108.5%)
$346.31 M(+3.5%)
Sept 2021
-
$48.43 M(-60.3%)
$334.59 M(-5.0%)
June 2021
$352.16 M(+71.6%)
$122.02 M(+63.0%)
$352.16 M(+28.1%)
Mar 2021
-
$74.87 M(-16.1%)
$274.94 M(+10.2%)
Dec 2020
-
$89.27 M(+35.2%)
$249.54 M(+8.2%)
Sept 2020
-
$66.01 M(+47.4%)
$230.69 M(+12.4%)
June 2020
$205.22 M(+13.0%)
$44.79 M(-9.5%)
$205.22 M(-5.2%)
Mar 2020
-
$49.47 M(-29.7%)
$216.37 M(+4.7%)
Dec 2019
-
$70.42 M(+73.7%)
$206.56 M(+13.1%)
Sept 2019
-
$40.54 M(-27.5%)
$182.71 M(+0.6%)
June 2019
$181.62 M(+6.6%)
$55.95 M(+41.1%)
$181.62 M(-4.7%)
Mar 2019
-
$39.66 M(-14.8%)
$190.51 M(+10.4%)
Dec 2018
-
$46.56 M(+18.0%)
$172.50 M(+4.5%)
Sept 2018
-
$39.45 M(-39.2%)
$165.12 M(-3.1%)
June 2018
$170.37 M(+18.5%)
$64.84 M(+199.5%)
$170.37 M(+8.9%)
Mar 2018
-
$21.65 M(-44.7%)
$156.38 M(-2.1%)
Dec 2017
-
$39.18 M(-12.3%)
$159.75 M(-1.5%)
Sept 2017
-
$44.70 M(-12.1%)
$162.19 M(+12.9%)
June 2017
$143.72 M(-0.3%)
$50.85 M(+103.2%)
$143.72 M(+11.0%)
Mar 2017
-
$25.02 M(-39.9%)
$129.52 M(-8.6%)
Dec 2016
-
$41.63 M(+58.8%)
$141.64 M(+2.2%)
Sept 2016
-
$26.22 M(-28.4%)
$138.55 M(-3.9%)
June 2016
$144.16 M(+3.4%)
$36.65 M(-1.3%)
$144.16 M(-0.3%)
Mar 2016
-
$37.14 M(-3.6%)
$144.65 M(+4.6%)
Dec 2015
-
$38.54 M(+21.1%)
$138.29 M(+2.1%)
Sept 2015
-
$31.83 M(-14.3%)
$135.47 M(-2.8%)
June 2015
$139.36 M(+1.9%)
$37.14 M(+20.7%)
$139.36 M(-0.6%)
Mar 2015
-
$30.78 M(-13.9%)
$140.14 M(-2.9%)
Dec 2014
-
$35.73 M(+0.0%)
$144.30 M(+3.1%)
Sept 2014
-
$35.72 M(-5.8%)
$139.90 M(+2.3%)
June 2014
$136.76 M(+10.7%)
$37.92 M(+8.6%)
$136.76 M(+6.2%)
Mar 2014
-
$34.93 M(+11.5%)
$128.83 M(+1.5%)
Dec 2013
-
$31.32 M(-3.9%)
$126.92 M(+0.0%)
Sept 2013
-
$32.59 M(+8.7%)
$126.88 M(+2.7%)
June 2013
$123.56 M(-2.5%)
$29.99 M(-9.2%)
$123.56 M(-5.7%)
Mar 2013
-
$33.02 M(+5.6%)
$130.99 M(-1.1%)
Dec 2012
-
$31.29 M(+6.9%)
$132.43 M(+8.9%)
Sept 2012
-
$29.26 M(-21.8%)
$121.58 M(-4.1%)
June 2012
$126.75 M(-0.4%)
$37.41 M(+8.6%)
$126.75 M(+2.2%)
Mar 2012
-
$34.46 M(+68.6%)
$124.00 M(+1.7%)
Dec 2011
-
$20.44 M(-40.6%)
$121.93 M(-6.9%)
Sept 2011
-
$34.43 M(-0.7%)
$130.92 M(+2.9%)
June 2011
$127.19 M(+14.3%)
$34.67 M(+7.1%)
$127.19 M(+2.3%)
Mar 2011
-
$32.39 M(+10.0%)
$124.30 M(+8.0%)
Dec 2010
-
$29.43 M(-4.1%)
$115.13 M(+1.1%)
Sept 2010
-
$30.70 M(-3.4%)
$113.93 M(+2.4%)
June 2010
$111.26 M(-0.1%)
$31.78 M(+36.9%)
$111.26 M(+1.4%)
Mar 2010
-
$23.22 M(-17.8%)
$109.77 M(-3.9%)
Dec 2009
-
$28.23 M(+0.7%)
$114.28 M(+1.5%)
Sept 2009
-
$28.03 M(-7.5%)
$112.58 M(+1.1%)
June 2009
$111.32 M(-3.5%)
$30.29 M(+9.2%)
$111.32 M(-2.6%)
Mar 2009
-
$27.73 M(+4.5%)
$114.28 M(-1.5%)
Dec 2008
-
$26.53 M(-0.9%)
$115.96 M(-2.9%)
Sept 2008
-
$26.77 M(-19.5%)
$119.45 M(+3.6%)
June 2008
$115.32 M(+27.4%)
$33.25 M(+13.1%)
$115.32 M(+5.4%)
Mar 2008
-
$29.41 M(-2.0%)
$109.40 M(+5.5%)
Dec 2007
-
$30.02 M(+32.6%)
$103.67 M(+10.6%)
Sept 2007
-
$22.64 M(-17.2%)
$93.75 M(+3.6%)
June 2007
$90.50 M
$27.33 M(+15.4%)
$90.50 M(-2.1%)
DateAnnualQuarterlyTTM
Mar 2007
-
$23.68 M(+17.8%)
$92.43 M(+7.9%)
Dec 2006
-
$20.11 M(+3.7%)
$85.66 M(-2.1%)
Sept 2006
-
$19.39 M(-33.7%)
$87.47 M(+2.2%)
June 2006
$85.59 M(+15.0%)
$29.25 M(+73.0%)
$85.59 M(+12.6%)
Mar 2006
-
$16.91 M(-22.9%)
$76.05 M(-5.0%)
Dec 2005
-
$21.92 M(+25.2%)
$80.08 M(+9.0%)
Sept 2005
-
$17.50 M(-11.2%)
$73.49 M(-1.3%)
June 2005
$74.43 M(+13.5%)
$19.71 M(-5.9%)
$74.43 M(+3.1%)
Mar 2005
-
$20.95 M(+36.6%)
$72.22 M(+9.3%)
Dec 2004
-
$15.33 M(-16.9%)
$66.06 M(-3.8%)
Sept 2004
-
$18.44 M(+5.4%)
$68.67 M(+4.8%)
June 2004
$65.55 M(+18.7%)
$17.50 M(+18.3%)
$65.55 M(+2.2%)
Mar 2004
-
$14.79 M(-17.5%)
$64.14 M(+2.8%)
Dec 2003
-
$17.94 M(+17.0%)
$62.40 M(+23.2%)
Sept 2003
-
$15.33 M(-4.7%)
$50.64 M(-8.3%)
June 2003
$55.24 M(+99.7%)
$16.08 M(+23.2%)
$55.24 M(+54.8%)
Mar 2003
-
$13.05 M(+111.0%)
$35.69 M(+4.5%)
Dec 2002
-
$6.18 M(-69.0%)
$34.16 M(-10.0%)
Sept 2002
-
$19.92 M(-675.7%)
$37.94 M(+37.1%)
June 2002
$27.67 M(-40.3%)
-$3.46 M(-130.1%)
$27.67 M(-37.5%)
Mar 2002
-
$11.51 M(+15.5%)
$44.26 M(+6.1%)
Dec 2001
-
$9.97 M(+3.4%)
$41.72 M(-4.5%)
Sept 2001
-
$9.64 M(-26.5%)
$43.67 M(-5.8%)
June 2001
$46.37 M(+19.7%)
$13.13 M(+46.3%)
$46.37 M(+2.9%)
Mar 2001
-
$8.97 M(-24.7%)
$45.07 M(-1.8%)
Dec 2000
-
$11.92 M(-3.5%)
$45.91 M(+11.5%)
Sept 2000
-
$12.35 M(+4.4%)
$41.19 M(+6.3%)
June 2000
$38.74 M(+36.4%)
$11.83 M(+20.5%)
$38.74 M(+1.9%)
Mar 2000
-
$9.81 M(+36.3%)
$38.01 M(+10.2%)
Dec 1999
-
$7.20 M(-27.3%)
$34.50 M(+5.8%)
Sept 1999
-
$9.90 M(-10.8%)
$32.60 M(+14.8%)
June 1999
$28.40 M(+35.9%)
$11.10 M(+76.2%)
$28.40 M(+15.4%)
Mar 1999
-
$6.30 M(+18.9%)
$24.60 M(+7.0%)
Dec 1998
-
$5.30 M(-7.0%)
$23.00 M(+8.0%)
Sept 1998
-
$5.70 M(-21.9%)
$21.30 M(+1.9%)
June 1998
$20.90 M(+67.2%)
$7.30 M(+55.3%)
$20.90 M(+10.6%)
Mar 1998
-
$4.70 M(+30.6%)
$18.90 M(+22.7%)
Dec 1997
-
$3.60 M(-32.1%)
$15.40 M(+1.3%)
Sept 1997
-
$5.30 M(0.0%)
$15.20 M(+21.6%)
June 1997
$12.50 M(+27.6%)
$5.30 M(+341.7%)
$12.50 M(+19.0%)
Mar 1997
-
$1.20 M(-64.7%)
$10.50 M(-11.8%)
Dec 1996
-
$3.40 M(+30.8%)
$11.90 M(+15.5%)
Sept 1996
-
$2.60 M(-21.2%)
$10.30 M(+5.1%)
June 1996
$9.80 M(+34.2%)
$3.30 M(+26.9%)
$9.80 M(+8.9%)
Mar 1996
-
$2.60 M(+44.4%)
$9.00 M(+5.9%)
Dec 1995
-
$1.80 M(-14.3%)
$8.50 M(+13.3%)
Sept 1995
-
$2.10 M(-16.0%)
$7.50 M(+2.7%)
June 1995
$7.30 M(+15.9%)
$2.50 M(+19.0%)
$7.30 M(+10.6%)
Mar 1995
-
$2.10 M(+162.5%)
$6.60 M(0.0%)
Dec 1994
-
$800.00 K(-57.9%)
$6.60 M(+1.5%)
Sept 1994
-
$1.90 M(+5.6%)
$6.50 M(+3.2%)
June 1994
$6.30 M(+40.0%)
$1.80 M(-14.3%)
$6.30 M(+1.6%)
Mar 1994
-
$2.10 M(+200.0%)
$6.20 M(+12.7%)
Dec 1993
-
$700.00 K(-58.8%)
$5.50 M(-3.5%)
Sept 1993
-
$1.70 M(0.0%)
$5.70 M(+26.7%)
June 1993
$4.50 M(+15.4%)
$1.70 M(+21.4%)
$4.50 M(-2.2%)
Mar 1993
-
$1.40 M(+55.6%)
$4.60 M(-8.0%)
Dec 1992
-
$900.00 K(+80.0%)
$5.00 M(+16.3%)
Sept 1992
-
$500.00 K(-72.2%)
$4.30 M(+10.3%)
June 1992
$3.90 M(+116.7%)
$1.80 M(0.0%)
$3.90 M(+34.5%)
Mar 1992
-
$1.80 M(+800.0%)
$2.90 M(+141.7%)
Dec 1991
-
$200.00 K(+100.0%)
$1.20 M(+33.3%)
Sept 1991
-
$100.00 K(-87.5%)
$900.00 K(-50.0%)
June 1991
$1.80 M(+63.6%)
$800.00 K(+700.0%)
$1.80 M(+38.5%)
Mar 1991
-
$100.00 K(-200.0%)
$1.30 M(-38.1%)
Dec 1990
-
-$100.00 K(-110.0%)
$2.10 M(0.0%)
Sept 1990
-
$1.00 M(+233.3%)
$2.10 M(+90.9%)
June 1990
$1.10 M
$300.00 K(-66.7%)
$1.10 M(+37.5%)
Mar 1990
-
$900.00 K(-1000.0%)
$800.00 K(-900.0%)
Dec 1989
-
-$100.00 K(<-9900.0%)
-$100.00 K(<-9900.0%)
Sept 1989
-
$0.00
$0.00

FAQ

  • What is Bio-Techne annual cash flow from operations?
  • What is the all time high annual CFO for Bio-Techne?
  • What is Bio-Techne annual CFO year-on-year change?
  • What is Bio-Techne quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Bio-Techne?
  • What is Bio-Techne quarterly CFO year-on-year change?
  • What is Bio-Techne TTM cash flow from operations?
  • What is the all time high TTM CFO for Bio-Techne?
  • What is Bio-Techne TTM CFO year-on-year change?

What is Bio-Techne annual cash flow from operations?

The current annual CFO of TECH is $298.98 M

What is the all time high annual CFO for Bio-Techne?

Bio-Techne all-time high annual cash flow from operations is $352.16 M

What is Bio-Techne annual CFO year-on-year change?

Over the past year, TECH annual cash flow from operations has changed by +$44.59 M (+17.53%)

What is Bio-Techne quarterly cash flow from operations?

The current quarterly CFO of TECH is $63.89 M

What is the all time high quarterly CFO for Bio-Techne?

Bio-Techne all-time high quarterly cash flow from operations is $122.02 M

What is Bio-Techne quarterly CFO year-on-year change?

Over the past year, TECH quarterly cash flow from operations has changed by -$19.23 M (-23.13%)

What is Bio-Techne TTM cash flow from operations?

The current TTM CFO of TECH is $303.49 M

What is the all time high TTM CFO for Bio-Techne?

Bio-Techne all-time high TTM cash flow from operations is $352.16 M

What is Bio-Techne TTM CFO year-on-year change?

Over the past year, TECH TTM cash flow from operations has changed by +$27.06 M (+9.79%)